EquityZen Growth Technology Fund LLC - Series 1744
Raised
$137K
Investors
10
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1744 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on 2023-11-13, raising $137K from 10 investors under Rule 506(b) and Section 3(c)(1). The fund has a $10K minimum investment and is part of EquityZen's pre-IPO secondary marketplace platform, which operates over 1,800 related SPV entities.
This pre-IPO vehicle follows the typical EquityZen platform template: a small-scale 506(b)/3(c)(1) pooled fund with a retail-accessible $10K minimum. The $137K raise and 10-investor count ($13.7K average check) are consistent with EquityZen's series-by-series SPV model for enabling secondary transactions in private growth companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.